Intellectual Property and Trade

  • Your Selections:

Refine Results

date

Tags

Proposal At WTO To Waive Intellectual Property Rights To COVID-19 Technologies Not In World’s Best Interest, Paper Argues

Cato Institute: An Unnecessary Proposal: A WTO Waiver of Intellectual Property Rights for COVID-19 Vaccines James Bacchus, distinguished university professor of global affairs and director of the Center for Global Economic and Environmental Opportunity at the University of Central Florida and adjunct scholar at the Cato Institute, discusses a proposal…

Opinion Pieces Address Various Topics Related To COVID-19 Vaccine, Including Role Of Pharmaceutical Industry, Access, Intellectual Property Protections

New York Times: Don’t Fall for Big Pharma’s Savior Act Stephen Buranyi, science journalist and visiting lecturer at the European Business School (12/17). Scientific American: How to Expand Access to COVID Vaccines without Compromising the Science Peter Doshi, associate professor of pharmaceutical health services research at the University of Maryland…

Amid Wait For COVID-19 Vaccines, LMICs Push For WTO To Temporarily Waive Intellectual Property Protections For Vaccines, Treatments, Diagnostics

Devex: At WTO, a battle for access to COVID-19 vaccines “High-income countries appear to be maneuvering to avoid a showdown at the World Trade Organization’s General Council meeting, beginning Wednesday, over a proposal to temporarily waive intellectual property protections for all COVID-19 vaccines and other technologies. With the United Kingdom,…

Opinion Pieces Address Topics Related To COVID-19 Pandemic, Including Sustaining Global TB Efforts; Intellectual Property Rights; Vaccine Access, Distribution; Impact On Girls

Global Health NOW: A 2-Front Battle: COVID-19 Must Reinvigorate the Fight Against TB Ersin Topcuoglu, director of the USAID-funded Health Systems for Tuberculosis Project at Management Sciences for Health (12/11). IPS: Intellectual Property Monopolies Block Vaccine Access Anis Chowdhury, adjunct professor at Western Sydney University & University of New South…

Blog Posts, Releases Discuss Various Aspects Of COVID-19 Pandemic, Including Inequities In Medical Oxygen Access; Call To Waive Intellectual Property Rules; Health Information Management

BMJ Opinion: Covid-19 has turned the spotlight on the uneven provision of oxygen — a stark health inequity Kevin Watkins, CEO of Save the Children U.K., and Adamu Isah, chief of party for the INSPIRING Project at Save the Children Nigeria (12/11). Brookings Institution: The promise and peril of anti-pandemic…

Editorials, Opinion Pieces Discuss Various Aspects Of COVID-19 Response, Including Vaccines, Human Rights, Economic Recovery, Intellectual Property Protections

Christian Science Monitor: A critical aspect of the vaccination campaign Editorial Board (12/9). IPS: Human Rights Must Be at the Heart of the COVID-19 Recovery Siddharth Chatterjee, United Nations resident coordinator in Kenya (12/9). New York Times: The Coronavirus Vaccines Were Developed in Record Speed. Now, the Hard Part Editorial…

Pfizer-BioNTech To File With FDA For Emergency Authorization Of Coronavirus Vaccine; Oxford Vaccine Results Expected By Year’s End; Wealthy Nations Urged To Waive IP Rights On, Create Humanitarian Stockpile Of Vaccines

CNBC: Pfizer and BioNTech to request emergency authorization from FDA for Covid vaccine “Pfizer and BioNTech will apply Friday for an emergency use authorization from the Food and Drug Administration for their coronavirus vaccine. If Pfizer’s application is approved, the vaccine will likely be limited and rolled out in phases,…

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.